TGFB1 and glioblastoma: Given the immunosuppressive role of TGFβ, the incorporation of TGFβ blockade further enhances survival outcomes.<h4>Conclusion</h4>We comprehensively outline how SMCs can be used in conjunction with ICIs to treat GBM and propose strategies to maximize SMC efficacy.